4-(3-Fluoro-4-methylphenyl)-2H-pyrido[2,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide

Catalog No. :
ACXGSP729
CAS No. :
1325303-39-6
Molecular Formula :
C13H10FN3O3S
Molecular Weight :
307.31

IUPAC Name:4-(3-fluoro-4-methylphenyl)-2H-pyrido[2,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide

4-(3-Fluoro-4-methylphenyl)-2H-pyrido[2,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$323.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(3-Fluoro-4-methylphenyl)-2H-pyrido[2,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide
IUPAC Name4-(3-fluoro-4-methylphenyl)-2H-pyrido[2,3-e][1,2,4]thiadiazin-3(4H)-one 1,1-dioxide
MDL No.MFCD19104934
Molecular FormulaC13H10FN3O3S
Molecular Weight307.31
SMILESO=S1(NC(N(C2=NC=CC=C21)C3=CC=C(C(F)=C3)C)=O)=O
InChI KeyFLVRHWXELPWKBV-UHFFFAOYSA-N
Synonym4-(3-fluoro-4-methylphenyl)-2H,3H,4H-1lambda6-pyrido[2,3-e][1,2,4]thiadiazine-1,1,3-trione;2H-Pyrido[2,3-e]-1,2,4-thiadiazin-3(4H)-one, 4-(3-fluoro-4-methylphenyl)-, 1,1-dioxide
CAS No.1325303-39-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACXGSP729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXGSP729 route product structure diagram
    ACXGSP7291325303-39-6
Inquiry

2. ACXGSP729 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKNJF602 route compound structure diagram
    ACKNJF60239998-81-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACXGSP729 route product structure diagram
    ACXGSP7291325303-39-6
Inquiry

Comments (0)